Zomedica Corp. (ZOMDF) stock
ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.08−0.00 (-0.55%)
Close on Oct 19, 2026Market cap $77.40MP/E –Yield –
Zomedica net income
Net income is the profit left for shareholders after every expense, interest and tax.
Zomedica's net income for the twelve months ending Jun 30, 2026 was -$18.95M. For fiscal 2025 it was -$81.86M. The highest annual figure on record is -$5.74M in fiscal 2016.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$81.86M | – |
| FY2024 | Dec 31, 2024 | -$46.98M | – |
| FY2023 | Dec 31, 2023 | -$34.53M | – |
| FY2022 | Dec 31, 2022 | -$17.02M | – |
| FY2021 | Dec 31, 2021 | -$18.38M | – |
| FY2020 | Dec 31, 2020 | -$16.91M | – |
| FY2019 | Dec 31, 2019 | -$19.78M | – |
| FY2018 | Dec 31, 2018 | -$16.65M | – |
| FY2017 | Dec 31, 2017 | -$8.07M | – |
| FY2016 | Dec 31, 2016 | -$5.74M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.77M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.53M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.53M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.12M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.40M | – |
| Q1 FY2025 | Mar 31, 2025 | -$63.81M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.19M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.70M | – |
| Q2 FY2024 | Jun 30, 2024 | -$23.93M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.16M | – |
| Q4 FY2023 | Dec 31, 2023 | -$22.41M | – |
| Q3 FY2023 | Sep 30, 2023 | -$491.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.25M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.39M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.81M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.00M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.27M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.94M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.29M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.35M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.71M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.04M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.17M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.98M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.31M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.45M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.86M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.85M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.40M | – |
| Q1 FY2019 | Mar 31, 2019 | -$11.68M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.42M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.91M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.14M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.17M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.56M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.08M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.59M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.83M | – |
See a number that looks wrong?